SaaS Diagnostics

Valuation Optimizer for SaaS Companies

Evaluate your SaaS company’s EBITDA multiple optimization and exit value against the benchmarks that matter to institutional buyers and growth investors.

Run the Diagnostic

How SaaS Valuation Multiples Are Actually Set

SaaS companies are frequently valued on ARR multiples rather than EBITDA, but the range is wide — and where your company lands within it is not random. The primary drivers are NRR (above 110% is strong, above 120% is premium), gross margin (above 70% is expected, above 80% commands a premium), ARR growth rate, and whether the company satisfies the Rule of 40.

Buyer type also matters: strategic acquirers weight product differentiation and customer base overlap; private equity sponsors weight management team quality and EBITDA conversion potential; growth equity investors weight NRR and expansion mechanics most heavily. The Valuation Optimizer is structured to help you understand which buyer type would assign the highest value to your current business — and what to change to improve that outcome.


Closing the Gap Between Current and Target Multiple

The Valuation Optimizer identifies the specific levers in your SaaS business — pricing architecture, customer concentration, ARR composition, gross margin structure — that are currently compressing your multiple relative to comparable transactions. It does not generate estimates or projections. It benchmarks your current state against the characteristics of SaaS companies that have transacted at premium multiples, then ranks the remediation priorities by impact.

For most mid-market SaaS companies, two or three operational changes produce the majority of the multiple improvement. The diagnostic identifies which two or three those are for your specific situation, rather than providing a generic improvement framework that applies equally to every company.

Frequently Asked Questions

What inputs does the Valuation Optimizer use for SaaS companies?

The diagnostic uses ARR composition (new logo vs. expansion vs. contraction), NRR, gross margin, growth rate, customer concentration, and contract structure. These are the primary inputs used by institutional buyers to set ARR multiples in SaaS transactions.

Does the Valuation Optimizer produce a specific valuation number?

No. The diagnostic benchmarks your business characteristics against SaaS companies that have transacted at various multiples and identifies the gaps between your current profile and the profile of companies that received premium multiples. Producing a specific valuation number requires a full financial model, banker engagement, and access to comparable transaction data not available in a diagnostic format.

How does gross margin affect SaaS valuation?

Gross margin signals the scalability of the revenue model. SaaS companies with gross margins above 70% are delivering software economics; those below 60% are typically carrying significant professional services, hosting, or third-party license costs that compress margin and reduce the multiple a buyer will pay. Improving gross margin from 65% to 75% often has a larger valuation impact than an equivalent improvement in ARR growth rate.

Run Valuation Optimizer for Your SaaS Company

Answer 12 questions and get a full diagnostic breakdown with prioritized remediation items.

Start the Diagnostic

AI-generated content · AI Disclaimer